Posts
CNXU — Day One Risk Assessment for a Preclinical Listing
Listing day posts tend to be either dismissive or enthusiastic. Here's an attempt at neither — just a clear map of what the risk profile looks like for a preclinical medical device company on its first day of trading. **Risk 1: Preclinical stage with no human data** Everything demonstrated so …
CNXU — Breaking Down the Platform, the Market Targets, and What the Regulatory Timeline Actually Means
Conexeu is preclinical and listed today. Most new listings in this category get either ignored or irrationally bid up in the first few sessions. Here's what the underlying business actually looks like stripped of the listing day noise. **The CXU Platform:** The core technology is a patented bioregenerative extracellular matrix. …
What do people think of The Metals Company (TMC)? Generational opportunity or scam?
I like everything in theory about The Metals Company. It's the idea that they can collect tons of precocious minerals from the sea bed with minimal environmental or human impact. The ocean covers about 70% of the Earth. Why limit ourselves to just mining land where we also want to …
KIDZ 3.2 million mc pivotting to ai data center and neo cloud hosting.
KIDZ just announced moving and pivotting to AI data computing and AI data neo cloud hosting. its a 3.3 million marketcap and the news was released just a few hours ago. So we are early to realize the pivot they got a 100 million equity deal with chardan capital. this …
RZLV currently primed for a nice squeeze - Current price is around $2.60
Right now almost 100% of shorts are bought up. Insiders have been spending millions buying up stock. Blackrock is quietly acquiring millions of shares. The only person who owns more is the current CEO. Wall Street analysts are projecting it will go to $10-11 by the end of the year. …
BioLineRx (BLRX) and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
On May 22, 2026 BioLineRx and Hemispherian spotlighted GLIX1 at ASCO 2026, backed by strong preclinical data and an enrolling Phase 1/2a glioblastoma trial. New results show GLIX1’s TET2-targeting mechanism and synergistic activity with PARP inhibitors, reinforcing its potential in glioblastoma and broader solid tumor indications.
Breaking News - CABA’s Phase 1/2 RESET Clinical Trial Safety and Efficacy Results Abstracts to Be Presented at EULAR Conference in London Published HERE TWO Weeks Early - Lupus, Scleroderma and Myositis - RESE-CEL Effective against SLE, Lupus Nephritis and One Form of Myositis
CABA Big news. CABA abstracts for the upcoming EULAR conference are now published and online. Screenshots of all the abstracts here. This morning, I found CABA’s abstracts it will present in 2 weeks at the EULAR conference in London published on EULAR’s website in a 2500 page compendium of abstracts …
22 MAY 2026, WHAT ARE THE BIGGEST LOSERS AND WHY ?
THE BIGGEST LOSERS FOR 22 MAY 2026 PRE-MARKET |Company|Ticker|Why It’s Falling| |:-|:-|:-| |FuelCell Energy Inc.|FCEL|Despite prior rallies, traders are taking profits after aggressive clean-energy speculation. Highly volatile stock. | |Virgin Galactic Holdings Inc.|SPCE|Ongoing concerns about profitability and cash burn continue hurting sentiment in speculative space stocks. | |JetBlue Airways Corporation|JBLU|Airline …
22 MAY 2026 , THE BIGGEST WINNERS AND WHY ?
THE BIGGEST WINNERS 22 MAY 2026 |Company|Ticker|Price|Gain Today|Why It’s Moving| |:-|:-|:-|:-|:-| |Amesite Inc.|AMST|\~$1.73|\+120%|Massive speculative momentum and unusually high trading volume. Traders are piling into low-float AI-related names.| |NextNRG Inc.|NXXT|\~$0.82|\+100%|Retail traders pushing the stock higher after momentum breakout activity and heavy volume. | |Meiwu Technology Company Limited|WNW|\~$4.75|\+97%|Extremely volatile micro-cap move likely …
Asymmetric bet on power generation
The case for HYLN (Hyliion) They just got UL certified, made deals with the army and navy and NASA is interested. Also just met with Jensen from NVDA who then said we need 1000x more power. If this gets BE valuation, it would be a 450$ stock, currently trading at …